• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Tissue plasminogen activator treatment of postvitrectomy pupillary fibrin membrane].

作者信息

Maeno T, Maeda N, Ikeda T, Tano Y

机构信息

Eye Clinic, Osaka National Hospital, Japan.

出版信息

Nippon Ganka Gakkai Zasshi. 1991 Nov;95(11):1124-8.

PMID:1759654
Abstract

Twenty-five micrograms of human recombinant tissue plasminogen activator (tPA) was injected via the corneoscleral limbus of 14 postvitrectomy aphakic eyes with prominent pupillary fibrin membranes. Fibrinolysis by tPA was initiated by thirty minutes after the injection, and the fibrin membrane was completely dissolved within sixty minutes. No toxicity attributed to tPA was observed clinically. Intraocular fluid was obtained during fluid-gas exchange after complete dissolution of fibrin and analyzed for decomposed fibrin products (FDP). Intraocular FDP was significantly higher (160 +/- 250 micrograms/ml) than normal after tPA treatment. Intraocular tPA administration is a potent modality to treat postvitrectomy fibrin membrane. Fluid-gas exchange must be performed to eliminate as much FDP as possible to reduce postoperative inflammation.

摘要

相似文献

1
[Tissue plasminogen activator treatment of postvitrectomy pupillary fibrin membrane].
Nippon Ganka Gakkai Zasshi. 1991 Nov;95(11):1124-8.
2
Treatment of postvitrectomy fibrin formation with intraocular tissue plasminogen activator.
Arch Ophthalmol. 1988 Aug;106(8):1055-8. doi: 10.1001/archopht.1988.01060140211025.
3
Treatment of postvitrectomy fibrin pupillary block with tissue plasminogen activator.
Am J Ophthalmol. 1989 Aug 15;108(2):170-5. doi: 10.1016/0002-9394(89)90013-5.
4
The lowest effective dose of tissue plasminogen activator for fibrinolysis of postvitrectomy fibrin.
Retina. 1992;12(3 Suppl):S75-9. doi: 10.1097/00006982-199212031-00016.
5
Tissue plasminogen activator for postvitrectomy fibrin formation.
Ophthalmology. 1990 Feb;97(2):184-9. doi: 10.1016/s0161-6420(90)32618-0.
6
[Treatment of intraocular fibrin formation with tissue plasminogen activator after vitrectomy].玻璃体切除术后用组织型纤溶酶原激活剂治疗眼内纤维蛋白形成
Zhonghua Yan Ke Za Zhi. 1995 Jul;31(4):255-8.
7
[Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].[急性肺血栓栓塞症溶栓治疗中纤溶酶-α2纤溶酶抑制物复合物及FDP.D二聚体水平的测定]
Kokyu To Junkan. 1992 Jul;40(7):685-90.
8
The use of tissue plasminogen activator in postvitrectomy cases.
Int Ophthalmol. 1993 Apr;17(2):95-100. doi: 10.1007/BF00942782.
9
Tissue plasminogen activator for the treatment of postoperative intraocular fibrinous membranes following cataract surgery.组织型纤溶酶原激活剂用于治疗白内障手术后的眼内纤维蛋白膜。
Ger J Ophthalmol. 1995 Mar;4(2):75-9.
10
Treatment of intracameral fibrinous membranes with tissue plasminogen activator.用组织纤溶酶原激活剂治疗前房内纤维蛋白膜。
Ophthalmic Surg Lasers Imaging. 2003 Nov-Dec;34(6):451-6.